Through the results of a unique technical collaboration between ARM and Synopsys, the process used by ARM licensees to port synthesizable ARM® microprocessor cores to their chosen technologies, has ...

Universal closed out its CinemaCon with an emotional first look at Jon M. Chu’s Wicked: For Good, with Cynthia Erivo and ...

Theater owners attending Universal's presentation in Las Vegas are the first members of the public to get a glimpse of the ...

Academy Award nominees Cynthia Erivo and Ariana Grande are back to Oz in 'Wicked: For Good,' opening in theaters November 21.

Universal's CinemaCon presentation merely name-checked some of their most eagerly anticipated 2026 titles, such as Christopher Nolan’s The Odyssey, Super Mario Bros. Movie 2, Shrek 5, Steven Spielberg ...

Synopsys (SNPS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Synopsys (SNPS) CEO Sassine Ghazi disclosed the sale of 11,366 shares at an average price of $463.75, for a total amount of $5.27M. The sale includes 10b5-1 plan transactions. Ghazi still owns ...

Stifel Nicolaus analyst Ruben Roy maintained a Buy rating on Synopsys (SNPS – Research Report) today and set a price target of $620.00. The company’s shares closed yesterday at $450.28.

Synopsys announced the launch of its Virtualizer Native Execution platform for Arm-based hardware, targeting key sectors like automotive and IoT, likely influencing its stock price movement.

"Synopsys technology is mission-critical to the productivity and capabilities of engineering teams from silicon to systems. By harnessing the performance of NVIDIA accelerated computing ...